Translation News and Research

RSS

CWRU grants technology transfer option to Disease Diagnostic Group to evaluate RAM device

Case Western Reserve University has granted a two-year technology transfer option to a research spinoff company developing a hand-held device that diagnoses malaria more quickly, simply and affordably than existing methods.

31 Jul 2013

Loyola to start construction on $137M medical research and education building in August

Loyola University Chicago will break ground Aug. 16 on a $137 million medical research and education building to support nearly 500 scientists and staff working together to improve human health.

23 Jul 2013

Scientists find way to sneak nanoparticles carrying anticancer drugs past cells of immune system

...

17 Jul 2013

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive top-line results from its ongoing Phase I trial of ALN-TTRsc, a subcutaneously administered RNAi therapeutic targeting the transthyretin gene for the treatment of TTR-mediated amyloidosis.

12 Jul 2013

Many pediatricians underuse interpreters to improve care of children, families with limited English

U.S. pediatricians are not using trained language interpreters as often as they should, despite evidence that such services are vital to improving the care of children and families with limited English, according to findings from research conducted jointly by the Johns Hopkins Children's Center and the American Academy of Pediatrics.

11 Jul 2013

Salk studies pave way to better computer object recognition and therapies for visual disorders

How is it possible for a human eye to figure out letters that are twisted and looped in crazy directions, like those in the little security test internet users are often given on websites?

3 Jul 2013

Fondation Leducq grants $6M to cardiovascular scientists to help advance cardiac regeneration therapeutics

The Fondation Leducq in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular disease, awarded a $6 million grant award to a new global research network of cardiovascular scientists which includes three researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.

2 Jul 2013

LSDF awards $1.5M grants to advance the development of health-related technologies

The Life Sciences Discovery Fund (LSDF) today announced nearly $1.5 million in Proof of Concept grants to Washington for-profit and non-profit organizations to foster translation of health-related technologies from idea to market launch.

2 Jul 2013

EGPAF welcomes new HIV/AIDS treatment and prevention guidelines

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) welcomes the World Health Organization (WHO)'s new HIV/AIDS treatment and prevention guidelines. For the first time, the 2013 guidelines combine recommendations across the continuum of HIV care and prevention programs, including expanding treatment eligibility for HIV-positive pregnant women, mothers, and children.

2 Jul 2013

Tiny RNA molecules work as powerful regulators of immune response in mammals

A team led by scientists at The Scripps Research Institute (TSRI) has identified a family of tiny RNA molecules that work as powerful regulators of the immune response in mammals. Mice who lack these RNA molecules lose their normal infection-fighting ability, whereas mice that overproduce them develop a fatal autoimmune syndrome.

1 Jul 2013

Synthetic biology technology could lead to new antibiotics, modified protein-generators

Synthetic biology researchers at Northwestern University, working with partners at Harvard Medical School, have for the first time synthesized ribosomes -- cell structures responsible for generating all proteins and enzymes in our bodies -- from scratch in a test tube.

30 Jun 2013

Oral probiotic supplement increases vitamin D levels in blood, says study

A study published in the Journal of Clinical Endocrinology & Metabolism is the first report of an oral probiotic supplement significantly increasing circulating vitamin D levels in the blood.

20 Jun 2013

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia.

19 Jun 2013

Moffitt Cancer Center, Advinus Therapeutics form strategic partnership

Moffitt Cancer Center announced a strategic partnership with Advinus Therapeutics to advance its discoveries to the clinics. Two promising targeted cancer therapies (Rb:Raf-1 disruptor and ROCK inhibitor) developed by Moffitt scientists are selected as the first set.

18 Jun 2013

Study examines how mobile technology might support deaf, hard-of-hearing college students

A small, pilot study is examining how mobile technology might support deaf and hard-of-hearing college students when an interpreter can't physically be present at the time the services are requested.

18 Jun 2013

Academies recommend ways to prevent antibiotic resistance, to develop antibiotics more quickly

Joint press release by the Academy of Sciences and Humanities in Hamburg and the German National Academy of Sciences Leopoldina

17 Jun 2013

Researchers produce first genome-wide investigation of cap-independent translation

Because of their central importance to biology, proteins have been the focus of intense research, particularly the manner in which they are produced from genetically coded templates-a process commonly known as translation. While the general mechanism of translation has been understood for some time, protein synthesis can initiate by more than one mechanism. One of the least well understood mechanisms is known as cap-independent translation.

17 Jun 2013

Study provides new insight into how pyrazinamide works

Pyrazinamide (PZA)-a frontline tuberculosis drug-kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB but resistance to PZA occurs frequently and can compromise treatment.

14 Jun 2013

Non-invasive odor analysis: A valuable technique for early diagnosis of melanoma

According to new research from the Monell Center and collaborating institutions, odors from human skin cells can be used to identify melanoma, the deadliest form of skin cancer. In addition to detecting a unique odor signature associated with melanoma cells, the researchers also demonstrated that a nanotechnology-based sensor could reliably differentiate melanoma cells from normal skin cells.

14 Jun 2013

Nation's leading experts join forces to accelerate effective treatments for brain tumors

The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.

10 Jun 2013

Translation News and Research

CWRU grants technology transfer option to Disease Diagnostic Group to evaluate RAM device

Loyola to start construction on $137M medical research and education building in August

Scientists find way to sneak nanoparticles carrying anticancer drugs past cells of immune system

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Many pediatricians underuse interpreters to improve care of children, families with limited English

Salk studies pave way to better computer object recognition and therapies for visual disorders

Fondation Leducq grants $6M to cardiovascular scientists to help advance cardiac regeneration therapeutics

LSDF awards $1.5M grants to advance the development of health-related technologies

EGPAF welcomes new HIV/AIDS treatment and prevention guidelines

Tiny RNA molecules work as powerful regulators of immune response in mammals

Synthetic biology technology could lead to new antibiotics, modified protein-generators

Oral probiotic supplement increases vitamin D levels in blood, says study

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

Moffitt Cancer Center, Advinus Therapeutics form strategic partnership

Study examines how mobile technology might support deaf, hard-of-hearing college students

Academies recommend ways to prevent antibiotic resistance, to develop antibiotics more quickly

Researchers produce first genome-wide investigation of cap-independent translation

Study provides new insight into how pyrazinamide works

Non-invasive odor analysis: A valuable technique for early diagnosis of melanoma

Nation's leading experts join forces to accelerate effective treatments for brain tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News